Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis

Cancer Medicine

Volumn 2, Issue 6, 2013, Pages 862-871

  Yamanaka, Kenya ^a,b   Petrulionis, Marius ^a   Lin, Shibo ^a   Gao, Chao ^a   Galli, Uwe ^a   Richter, Susanne ^a   Winkler, Susanne ^c   Houben, Philipp ^a   Schultze, Daniel ^a   Hatano, Etsuro ^b   Schemmer, Peter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b KYOTO UNIVERSITY   (Japan)

^c NOVARTIS PHARMA GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENTS; EVEROLIMUS; HEPATOCELLULAR CARCINOMA; LIVER TRANSPLANTATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84903944606     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.150     Document Type: Review

References (72)